How to manage the most talked-about drugs in all of pharmacy
New anti-obesity medications are effective but expensive and more than half of U.S. adults are eligible for them. Members who reach a healthier weight are less likely to have other health complications, so it’s great for the long run. But what about right now?
Plan sponsors need a game plan to balance the need for these drugs and contain the costs in their benefit plans.
Related content
![](/content/dam/o4-dam/images/professionals/pharmacies/2024-pharmacyinsightspodcast-sn3-ep1-youtube-1080x720-150.png)
2024: A new year promises a host of new drugs
See which trends to consider when assessing the pharmacy benefit, which new drugs may be flying under the radar and what’s coming this year.
![](/content/dam/o4-dam/images/professionals/pharmacies/tipping%20the%20scales-tiles-1080x720.jpg)
How to manage blockbuster anti-obesity drugs
The pricey weight management drugs work well, but users need coaching and support to maintain the benefits.
![](/content/dam/optum4/resources/images/rx-podcast-weight-loss-speakers-tile.jpg)
GLP-1 agonists: A new class of weight loss medications
In this conversation, discover how new weight loss drugs like Wegovy are changing obesity management and their connection to diabetes.
Top